We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy / V. Micheli, F. Bracchitta, A. Rizzo, A. Mancon, D. Mileto, A. Lombardi, P. Stefanelli, M.R. Gismondo. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - 75:3(2022 Aug 01), pp. 522-524. [10.1093/cid/ciab1044]
First Identification of the New Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant (B.1.1.529) in Italy
F. Bracchitta;M.R. GismondoUltimo
2022
Abstract
We identified the first case in Italy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 variant, using whole-genome sequencing in an Italian subject traveling from Mozambique. Specific mutation profiles deserve further investigations to clarify potential effects on vaccination efficacy. This case highlights the crucial role of rapid and continuous surveillance of SARS-CoV-2 variant circulation.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ciab1044.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
377.38 kB
Formato
Adobe PDF
|
377.38 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
